🇯🇵 Japan Country × Condition
solid tumor Clinical Trials in Japan
Active clinical trials for solid tumor with research sites in Japan. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 1, Phase 1, Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇯🇵 Japan
Active Trials in Japan (2)
NCT07094204 Phase 1
Recruiting
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Enrollment
364 pts
Country
🇯🇵 Japan
Astellas Pharma Inc
View Trial → NCT05423262 Phase 1, Phase 2
Recruiting
A Study of TRK-950 in Patients With Advanced Solid Tumors
Enrollment
49 pts
Country
🇯🇵 Japan
Toray Industries, Inc
View Trial → Frequently Asked Questions
How many solid tumor clinical trials are active in Japan?
There are currently 2 active clinical trials for solid tumor with sites in Japan, of which 2 are actively recruiting patients.
How can I join a solid tumor clinical trial in Japan?
To join a solid tumor clinical trial in Japan, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Japan directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are solid tumor trials in Japan?
Active solid tumor trials in Japan span Phase 1, Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology